Volume Deficiency of the Midface Clinical Trial
— 05DF1707Official title:
A Multi-center, Evaluator-blinded Study to Evaluate Effectiveness and Safety of HA Fillers for Lifting, Contouring and Correcting Volume Deficiency of the Midface Using an Individualized Treatment Algorithm
Verified date | April 2020 |
Source | Galderma R&D |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to investigate the degree of improvement in appearance after treatment with different hyaluronic acid (HA) fillers. Product selection is based on Investigator assessment of participant tissue coverage and main treatment goal (volumizing, lifting or contouring).
Status | Completed |
Enrollment | 90 |
Est. completion date | August 30, 2019 |
Est. primary completion date | August 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years to 55 Years |
Eligibility | Inclusion Criteria: - Male/Female 25 to 55 years old that needs lifting, contouring or volumization of the midface - Signed and dated informed consent Exclusion Criteria: - Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel and lidocain - Previous use of any permanent or semi-permanent facial tissue augmentation therapy or contouring with, lifting threads, permanent implants, or autologous fat in the treatment area - Previous use of any HA or collagen based facial tissue augmentation therapy in the facial area, any previous use of neurotoxin or any previous facial surgery - Any medical condition that in the opinion of the Investigator would make the participant unsuitable for inclusion |
Country | Name | City | State |
---|---|---|---|
Germany | Galderma Research Site | Munich | |
Italy | Galderma Research Site | Palermo | |
United Kingdom | Galderma Research Site | Edinburgh |
Lead Sponsor | Collaborator |
---|---|
Galderma R&D |
Germany, Italy, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of Participants With Aesthetic Improvement of Midface | A blinded evaluator assesses the improvement compared to baseline (pre-treatment) using a 5-graded scale; Worse, No change, Improved, Much improved or Very much improved. Aesthetic improvement of midface is defined as those participants assessed as Improved, Much improved or Very much improved. | 8 weeks | |
Secondary | Percentage of Participants With Improved Midface Volume | A blinded evaluator assessed the fullness of the midface by using a 4-graded scale where 1= fairly full and 4= substantial loss of fullness.
Improved midface volume was defined as at least a 1-grade decrease from baseline. |
8 weeks | |
Secondary | Percentage of Participants Assessed as Having Natural Treatment Results | Blinded evaluator assessed participants by answering Strongly agree/Agree/Neither agree nor disagree/Disagree/Strongly disagree to the question "Are the subject's treatment results natural looking?". Having natural treatment results is defined as being assessed with answers Strongly agree or Agree. | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05963204 -
A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator With a Skincare Regimen
|
N/A | |
Completed |
NCT05622851 -
Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers
|
N/A | |
Recruiting |
NCT06351358 -
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
|
N/A | |
Recruiting |
NCT05853224 -
An Interventional Study to Evaluate the Safety and Performance of Crosslinked Hyaluronic Acid Hydrogel
|
N/A |